Development and Validation of HPLC Method for Identification of Ramipril in Printed Tablets and Filaments
Introduction. 3D printing has shown its usefulness as a drug manufacturing technology over the past decade. However, the lack of regulated methods for quality control of finished printed drugs imposes a limitation on the widespread use of 3D printing methods in pharmaceutical practice. Thus, the dev...
Saved in:
| Main Authors: | V. V. Tihonova, O. A. Terenteva, K. A. Gusev, E. V. Flisyuk, D. N. Maimistov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2022-11-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/1379 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Three-dimensional printing of ramipril tablets by fused deposition modeling
by: O. A. Terenteva, et al.
Published: (2021-12-01) -
DISSOLUTION PROFILE STUDIES FOR RAMIPRIL AND LERCANIDIPINE FIXED-DOSE COMBINATION
by: A. A. Shadrin, et al.
Published: (2019-01-01) -
Forging the Future of Nanomedicine: A Comprehensive Review of 3D Printed Suppositories
by: Kacha Hardik A., et al.
Published: (2025-01-01) -
Development and validation of RP-HPLC method for determination of Atorvastatin calcium and Nicotinic acid in combined tablet dosage form
by: Jaiprakash N. Sangshetti, et al.
Published: (2016-09-01) -
THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2015-09-01)